In the article linked below, Dr. Lee Martin, a researcher in the Neuropathology Division discusses challenges in treating amyotrophic lateral sclerosis by modulating mitochondrial activity to protect neurons. An agent tested by the pharmaceutical company Trophos failed to achieve the desired survival effect in a Phase 3 clinical trial. However, the same approach may be tested for other conditions including spinal muscular atrophy and multiple sclerosis.